Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-05-25

AUTHORS

Yong Jia, Cai-Hong Yun, Eunyoung Park, Dalia Ercan, Mari Manuia, Jose Juarez, Chunxiao Xu, Kevin Rhee, Ting Chen, Haikuo Zhang, Sangeetha Palakurthi, Jaebong Jang, Gerald Lelais, Michael DiDonato, Badry Bursulaya, Pierre-Yves Michellys, Robert Epple, Thomas H. Marsilje, Matthew McNeill, Wenshuo Lu, Jennifer Harris, Steven Bender, Kwok-Kin Wong, Pasi A. Jänne, Michael J. Eck

ABSTRACT

The epidermal growth factor receptor (EGFR)-directed tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib and afatinib are approved treatments for non-small cell lung cancers harbouring activating mutations in the EGFR kinase, but resistance arises rapidly, most frequently owing to the secondary T790M mutation within the ATP site of the receptor. Recently developed mutant-selective irreversible inhibitors are highly active against the T790M mutant, but their efficacy can be compromised by acquired mutation of C797, the cysteine residue with which they form a key covalent bond. All current EGFR TKIs target the ATP-site of the kinase, highlighting the need for therapeutic agents with alternative mechanisms of action. Here we describe the rational discovery of EAI045, an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor. The crystal structure shows that the compound binds an allosteric site created by the displacement of the regulatory C-helix in an inactive conformation of the kinase. The compound inhibits L858R/T790M-mutant EGFR with low-nanomolar potency in biochemical assays. However, as a single agent it is not effective in blocking EGFR-driven proliferation in cells owing to differential potency on the two subunits of the dimeric receptor, which interact in an asymmetric manner in the active state. We observe marked synergy of EAI045 with cetuximab, an antibody therapeutic that blocks EGFR dimerization, rendering the kinase uniformly susceptible to the allosteric agent. EAI045 in combination with cetuximab is effective in mouse models of lung cancer driven by EGFR(L858R/T790M) and by EGFR(L858R/T790M/C797S), a mutant that is resistant to all currently available EGFR TKIs. More generally, our findings illustrate the utility of purposefully targeting allosteric sites to obtain mutant-selective inhibitors. More... »

PAGES

129-132

Journal

TITLE

Nature

ISSUE

7605

VOLUME

534

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/nature17960

DOI

http://dx.doi.org/10.1038/nature17960

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028060659

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27251290


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Allosteric Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Allosteric Site", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzeneacetamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cetuximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Multiple", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ErbB Receptors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Conformation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Multimerization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jia", 
        "givenName": "Yong", 
        "id": "sg:person.0677166101.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677166101.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
            "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yun", 
        "givenName": "Cai-Hong", 
        "id": "sg:person.0600312110.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600312110.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
            "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Eunyoung", 
        "id": "sg:person.0755167624.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755167624.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ercan", 
        "givenName": "Dalia", 
        "id": "sg:person.01077260754.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077260754.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manuia", 
        "givenName": "Mari", 
        "id": "sg:person.01013115571.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013115571.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Juarez", 
        "givenName": "Jose", 
        "id": "sg:person.01017445730.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017445730.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Chunxiao", 
        "id": "sg:person.01046707623.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046707623.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rhee", 
        "givenName": "Kevin", 
        "id": "sg:person.0672052330.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672052330.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Ting", 
        "id": "sg:person.016104577635.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016104577635.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Haikuo", 
        "id": "sg:person.01331013606.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331013606.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palakurthi", 
        "givenName": "Sangeetha", 
        "id": "sg:person.01353217430.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353217430.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
            "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jang", 
        "givenName": "Jaebong", 
        "id": "sg:person.01163706557.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163706557.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lelais", 
        "givenName": "Gerald", 
        "id": "sg:person.01317055442.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317055442.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DiDonato", 
        "givenName": "Michael", 
        "id": "sg:person.01035160034.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035160034.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bursulaya", 
        "givenName": "Badry", 
        "id": "sg:person.01271142403.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271142403.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michellys", 
        "givenName": "Pierre-Yves", 
        "id": "sg:person.01243347575.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243347575.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Epple", 
        "givenName": "Robert", 
        "id": "sg:person.01212567331.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212567331.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marsilje", 
        "givenName": "Thomas H.", 
        "id": "sg:person.01254747015.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254747015.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McNeill", 
        "givenName": "Matthew", 
        "id": "sg:person.01061464464.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061464464.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Wenshuo", 
        "id": "sg:person.0646074555.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646074555.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harris", 
        "givenName": "Jennifer", 
        "id": "sg:person.0646666743.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646666743.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA", 
          "id": "http://www.grid.ac/institutes/grid.418185.1", 
          "name": [
            "Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bender", 
        "givenName": "Steven", 
        "id": "sg:person.013337537643.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013337537643.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
            "Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wong", 
        "givenName": "Kwok-Kin", 
        "id": "sg:person.013640100622.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013640100622.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
            "Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "J\u00e4nne", 
        "givenName": "Pasi A.", 
        "id": "sg:person.0767133752.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767133752.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215 USA", 
            "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eck", 
        "givenName": "Michael J.", 
        "id": "sg:person.01212245744.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212245744.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature08622", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009588480", 
          "https://doi.org/10.1038/nature08622"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.3388", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044316748", 
          "https://doi.org/10.1038/nm.3388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.3854", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005299046", 
          "https://doi.org/10.1038/nm.3854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2013.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004440239", 
          "https://doi.org/10.1038/nrclinonc.2013.154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2014.83", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037851851", 
          "https://doi.org/10.1038/nrclinonc.2014.83"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-05-25", 
    "datePublishedReg": "2016-05-25", 
    "description": "The epidermal growth factor receptor (EGFR)-directed tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib and afatinib are approved treatments for non-small cell lung cancers harbouring activating mutations in the EGFR kinase, but resistance arises rapidly, most frequently owing to the secondary T790M mutation within the ATP site of the receptor. Recently developed mutant-selective irreversible inhibitors are highly active against the T790M mutant, but their efficacy can be compromised by acquired mutation of C797, the cysteine residue with which they form a key covalent bond. All current EGFR TKIs target the ATP-site of the kinase, highlighting the need for therapeutic agents with alternative mechanisms of action. Here we describe the rational discovery of EAI045, an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor. The crystal structure shows that the compound binds an allosteric site created by the displacement of the regulatory C-helix in an inactive conformation of the kinase. The compound inhibits L858R/T790M-mutant EGFR with low-nanomolar potency in biochemical assays. However, as a single agent it is not effective in blocking EGFR-driven proliferation in cells owing to differential potency on the two subunits of the dimeric receptor, which interact in an asymmetric manner in the active state. We observe marked synergy of EAI045 with cetuximab, an antibody therapeutic that blocks EGFR dimerization, rendering the kinase uniformly susceptible to the allosteric agent. EAI045 in combination with cetuximab is effective in mouse models of lung cancer driven by EGFR(L858R/T790M) and by EGFR(L858R/T790M/C797S), a mutant that is resistant to all currently available EGFR TKIs. More generally, our findings illustrate the utility of purposefully targeting allosteric sites to obtain mutant-selective inhibitors.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/nature17960", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2480038", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4729233", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2481873", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2478287", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435835", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435870", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7605", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "534"
      }
    ], 
    "keywords": [
      "allosteric inhibitors", 
      "allosteric site", 
      "wild-type receptor", 
      "epidermal growth factor receptor", 
      "C797S resistance", 
      "T790M mutant", 
      "growth factor receptor", 
      "mutant-selective inhibitors", 
      "cysteine residues", 
      "inactive conformation", 
      "EGFR dimerization", 
      "dimeric receptor", 
      "EGFR kinase", 
      "ATP site", 
      "tyrosine kinase inhibitor gefitinib", 
      "kinase", 
      "mutants", 
      "biochemical assays", 
      "kinase inhibitor gefitinib", 
      "EGFR mutants", 
      "rational discovery", 
      "factor receptor", 
      "mutations", 
      "allosteric agents", 
      "inhibitor gefitinib", 
      "active state", 
      "low nanomolar potency", 
      "alternative mechanism", 
      "irreversible inhibitor", 
      "differential potency", 
      "Acquired mutations", 
      "inhibitors", 
      "receptors", 
      "secondary T790M mutation", 
      "EGFR T790M", 
      "asymmetric manner", 
      "available EGFR TKIs", 
      "mouse model", 
      "sites", 
      "subunits", 
      "marked synergy", 
      "crystal structure", 
      "EGFR-TKI", 
      "helix", 
      "residues", 
      "dimerization", 
      "therapeutic agents", 
      "T790M mutation", 
      "EGFR", 
      "proliferation", 
      "conformation", 
      "cells", 
      "T790M", 
      "EAI045", 
      "assays", 
      "discovery", 
      "resistance", 
      "potency", 
      "cancer", 
      "lung cancer", 
      "mechanism", 
      "gefitinib", 
      "compounds", 
      "agents", 
      "manner", 
      "non-small cell lung cancer", 
      "covalent bonds", 
      "cell lung cancer", 
      "antibodies", 
      "erlotinib", 
      "TKIs", 
      "C797S", 
      "single agent", 
      "structure", 
      "action", 
      "synergy", 
      "combination", 
      "findings", 
      "cetuximab", 
      "afatinib", 
      "bonds", 
      "utility", 
      "treatment", 
      "state", 
      "model", 
      "need", 
      "efficacy", 
      "displacement", 
      "M mutation", 
      "mutant-selective irreversible inhibitors", 
      "M mutant", 
      "key covalent bond", 
      "current EGFR TKIs", 
      "drug-resistant EGFR mutants", 
      "L858R/T790M-mutant EGFR", 
      "T790M-mutant EGFR", 
      "mutant-selective allosteric inhibitors"
    ], 
    "name": "Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors", 
    "pagination": "129-132", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028060659"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/nature17960"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27251290"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/nature17960", 
      "https://app.dimensions.ai/details/publication/pub.1028060659"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_696.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/nature17960"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature17960'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature17960'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature17960'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature17960'


 

This table displays all metadata directly associated to this object as RDF triples.

452 TRIPLES      22 PREDICATES      149 URIs      136 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/nature17960 schema:about N0807489504c74896a396242df1a281ea
2 N3a8990156b7a4b6f8fdf53d8cd4370ee
3 N47fa5181238341139a27504680554840
4 N4b7f9e4c61c441728ac68382fa338c31
5 N513fcf8bf43443f28aa29e328704b87f
6 N645d0199012140a4b619fd82f9aded97
7 N64b5b583ce464ae495c926b291a4063c
8 N6ce5ba92ec734ec7ae65f47e1f7a4d40
9 N89949975560b46d3b6cb5afe8b239b02
10 N95f841c2ea174157bd1929421f497414
11 Na55e24eb947a453ebec3bfd8133a901d
12 Nae56d90e877c49e882cd3d91101b74fe
13 Ncab86bb9f9f648dfb74d8a08f57b43dc
14 Nd423939265f64c86a2625f1d991dd975
15 Nd5a02261586d414e8e819984629b7e08
16 Nd93f4b302b7b45769d23ef270d5bc559
17 Ndc2c38716b4c42a2a12ec5dc94491419
18 Ndd725aa96aef41a4affb59c0ba529e7d
19 Nee9e2ec07c3e4b15a25fe6d844cd32ba
20 Nfc4e38687fc1429b88f0531ecae0ba55
21 Nfe762edfc741484bbb15c0a88f5503f6
22 anzsrc-for:06
23 anzsrc-for:0601
24 schema:author Ne0e544b24d28465cb4c1c44e2fe493e4
25 schema:citation sg:pub.10.1038/nature08622
26 sg:pub.10.1038/nm.3388
27 sg:pub.10.1038/nm.3854
28 sg:pub.10.1038/nrclinonc.2013.154
29 sg:pub.10.1038/nrclinonc.2014.83
30 schema:datePublished 2016-05-25
31 schema:datePublishedReg 2016-05-25
32 schema:description The epidermal growth factor receptor (EGFR)-directed tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib and afatinib are approved treatments for non-small cell lung cancers harbouring activating mutations in the EGFR kinase, but resistance arises rapidly, most frequently owing to the secondary T790M mutation within the ATP site of the receptor. Recently developed mutant-selective irreversible inhibitors are highly active against the T790M mutant, but their efficacy can be compromised by acquired mutation of C797, the cysteine residue with which they form a key covalent bond. All current EGFR TKIs target the ATP-site of the kinase, highlighting the need for therapeutic agents with alternative mechanisms of action. Here we describe the rational discovery of EAI045, an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor. The crystal structure shows that the compound binds an allosteric site created by the displacement of the regulatory C-helix in an inactive conformation of the kinase. The compound inhibits L858R/T790M-mutant EGFR with low-nanomolar potency in biochemical assays. However, as a single agent it is not effective in blocking EGFR-driven proliferation in cells owing to differential potency on the two subunits of the dimeric receptor, which interact in an asymmetric manner in the active state. We observe marked synergy of EAI045 with cetuximab, an antibody therapeutic that blocks EGFR dimerization, rendering the kinase uniformly susceptible to the allosteric agent. EAI045 in combination with cetuximab is effective in mouse models of lung cancer driven by EGFR(L858R/T790M) and by EGFR(L858R/T790M/C797S), a mutant that is resistant to all currently available EGFR TKIs. More generally, our findings illustrate the utility of purposefully targeting allosteric sites to obtain mutant-selective inhibitors.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree true
36 schema:isPartOf N499024d1da3f44779e1d5429d934ef30
37 Nedc49744c51c4bc7a5502fc0062fc034
38 sg:journal.1018957
39 schema:keywords ATP site
40 Acquired mutations
41 C797S
42 C797S resistance
43 EAI045
44 EGFR
45 EGFR T790M
46 EGFR dimerization
47 EGFR kinase
48 EGFR mutants
49 EGFR-TKI
50 L858R/T790M-mutant EGFR
51 M mutant
52 M mutation
53 T790M
54 T790M mutant
55 T790M mutation
56 T790M-mutant EGFR
57 TKIs
58 action
59 active state
60 afatinib
61 agents
62 allosteric agents
63 allosteric inhibitors
64 allosteric site
65 alternative mechanism
66 antibodies
67 assays
68 asymmetric manner
69 available EGFR TKIs
70 biochemical assays
71 bonds
72 cancer
73 cell lung cancer
74 cells
75 cetuximab
76 combination
77 compounds
78 conformation
79 covalent bonds
80 crystal structure
81 current EGFR TKIs
82 cysteine residues
83 differential potency
84 dimeric receptor
85 dimerization
86 discovery
87 displacement
88 drug-resistant EGFR mutants
89 efficacy
90 epidermal growth factor receptor
91 erlotinib
92 factor receptor
93 findings
94 gefitinib
95 growth factor receptor
96 helix
97 inactive conformation
98 inhibitor gefitinib
99 inhibitors
100 irreversible inhibitor
101 key covalent bond
102 kinase
103 kinase inhibitor gefitinib
104 low nanomolar potency
105 lung cancer
106 manner
107 marked synergy
108 mechanism
109 model
110 mouse model
111 mutant-selective allosteric inhibitors
112 mutant-selective inhibitors
113 mutant-selective irreversible inhibitors
114 mutants
115 mutations
116 need
117 non-small cell lung cancer
118 potency
119 proliferation
120 rational discovery
121 receptors
122 residues
123 resistance
124 secondary T790M mutation
125 single agent
126 sites
127 state
128 structure
129 subunits
130 synergy
131 therapeutic agents
132 treatment
133 tyrosine kinase inhibitor gefitinib
134 utility
135 wild-type receptor
136 schema:name Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors
137 schema:pagination 129-132
138 schema:productId N07db1918c6d844218ac5758d8c766b68
139 N64de1643e6a34e06a6cf2bddf31eae06
140 N7eba623464c84542b54aa1308b9892d0
141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028060659
142 https://doi.org/10.1038/nature17960
143 schema:sdDatePublished 2021-11-01T18:27
144 schema:sdLicense https://scigraph.springernature.com/explorer/license/
145 schema:sdPublisher N33d2896e6c154dccb58d0f9a294f545c
146 schema:url https://doi.org/10.1038/nature17960
147 sgo:license sg:explorer/license/
148 sgo:sdDataset articles
149 rdf:type schema:ScholarlyArticle
150 N07db1918c6d844218ac5758d8c766b68 schema:name doi
151 schema:value 10.1038/nature17960
152 rdf:type schema:PropertyValue
153 N0807489504c74896a396242df1a281ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Cetuximab
155 rdf:type schema:DefinedTerm
156 N29c9f46848344ffdbcc175904a4de096 rdf:first sg:person.01077260754.53
157 rdf:rest Nb11727e784a6426db3a66c2e63c947d8
158 N2e21bb28a84b465786fd5a2cc4cf71d9 rdf:first sg:person.01254747015.25
159 rdf:rest N674659eda1d841669e76445246353c0b
160 N33d2896e6c154dccb58d0f9a294f545c schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 N34554e35fa3442fc849fd4a31648db03 rdf:first sg:person.01017445730.26
163 rdf:rest Nc31a04bd0d824fa38e73609eb7198b9d
164 N35d48a4dbce440e79a5f03926c44f09e rdf:first sg:person.01271142403.47
165 rdf:rest Nf5f929e19e3a4d53ae35154d5c35fc48
166 N3a8990156b7a4b6f8fdf53d8cd4370ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Disease Models, Animal
168 rdf:type schema:DefinedTerm
169 N3d6c610c237b4c1fbd424b6260f29d60 rdf:first sg:person.01212245744.44
170 rdf:rest rdf:nil
171 N40a0ef7656cf47c39c73f97cb92df687 rdf:first sg:person.013337537643.57
172 rdf:rest Nc3d0fcdda9334fe99dc2e3fc7505e7fc
173 N47fa5181238341139a27504680554840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Drug Synergism
175 rdf:type schema:DefinedTerm
176 N499024d1da3f44779e1d5429d934ef30 schema:issueNumber 7605
177 rdf:type schema:PublicationIssue
178 N4b7f9e4c61c441728ac68382fa338c31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Benzeneacetamides
180 rdf:type schema:DefinedTerm
181 N513fcf8bf43443f28aa29e328704b87f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Lung Neoplasms
183 rdf:type schema:DefinedTerm
184 N5b659addb83648abbc04e4e7d7eb8f5d rdf:first sg:person.01212567331.89
185 rdf:rest N2e21bb28a84b465786fd5a2cc4cf71d9
186 N645d0199012140a4b619fd82f9aded97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Cell Proliferation
188 rdf:type schema:DefinedTerm
189 N64b5b583ce464ae495c926b291a4063c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Antineoplastic Agents
191 rdf:type schema:DefinedTerm
192 N64de1643e6a34e06a6cf2bddf31eae06 schema:name pubmed_id
193 schema:value 27251290
194 rdf:type schema:PropertyValue
195 N674659eda1d841669e76445246353c0b rdf:first sg:person.01061464464.45
196 rdf:rest Nce4f4678ef65427e9bf0dc75d437da9b
197 N6ce5ba92ec734ec7ae65f47e1f7a4d40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name ErbB Receptors
199 rdf:type schema:DefinedTerm
200 N7eba623464c84542b54aa1308b9892d0 schema:name dimensions_id
201 schema:value pub.1028060659
202 rdf:type schema:PropertyValue
203 N839bf4e2f7494f5d858fecf7f564f625 rdf:first sg:person.01163706557.63
204 rdf:rest Nddf36e1428d441b19d84dbc7e4c35c98
205 N89949975560b46d3b6cb5afe8b239b02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Protein Conformation
207 rdf:type schema:DefinedTerm
208 N8bc6ff325681415eb2c09786d0f96754 rdf:first sg:person.01353217430.16
209 rdf:rest N839bf4e2f7494f5d858fecf7f564f625
210 N95f841c2ea174157bd1929421f497414 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Mice
212 rdf:type schema:DefinedTerm
213 Na3522de6ae6e450dbf3b079ddefa742d rdf:first sg:person.01035160034.34
214 rdf:rest N35d48a4dbce440e79a5f03926c44f09e
215 Na55e24eb947a453ebec3bfd8133a901d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Cell Line, Tumor
217 rdf:type schema:DefinedTerm
218 Na5c0abaa1aad4882ad3ac00567ff36d7 rdf:first sg:person.016104577635.69
219 rdf:rest Nf26ca6e651604e8b9dc69e3fbb313d1f
220 Naaedb446ccb64781901859d8035161eb rdf:first sg:person.0767133752.11
221 rdf:rest N3d6c610c237b4c1fbd424b6260f29d60
222 Nae56d90e877c49e882cd3d91101b74fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Mutant Proteins
224 rdf:type schema:DefinedTerm
225 Nb11727e784a6426db3a66c2e63c947d8 rdf:first sg:person.01013115571.32
226 rdf:rest N34554e35fa3442fc849fd4a31648db03
227 Nc31a04bd0d824fa38e73609eb7198b9d rdf:first sg:person.01046707623.60
228 rdf:rest Nf339a56e24a749619fe381ac44d11fc7
229 Nc3d0fcdda9334fe99dc2e3fc7505e7fc rdf:first sg:person.013640100622.46
230 rdf:rest Naaedb446ccb64781901859d8035161eb
231 Nc853152d9ccf495f8a12b61540529f7d rdf:first sg:person.0600312110.65
232 rdf:rest Nfb2cee6712bf4ac794861760d11e4d3d
233 Ncab86bb9f9f648dfb74d8a08f57b43dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Protein Multimerization
235 rdf:type schema:DefinedTerm
236 Nce4f4678ef65427e9bf0dc75d437da9b rdf:first sg:person.0646074555.85
237 rdf:rest Ne9738cbde0844d0985faa776121d602b
238 Nd423939265f64c86a2625f1d991dd975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
239 schema:name Allosteric Site
240 rdf:type schema:DefinedTerm
241 Nd5a02261586d414e8e819984629b7e08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
242 schema:name Protein Kinase Inhibitors
243 rdf:type schema:DefinedTerm
244 Nd93f4b302b7b45769d23ef270d5bc559 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
245 schema:name Drug Resistance, Neoplasm
246 rdf:type schema:DefinedTerm
247 Ndc2c38716b4c42a2a12ec5dc94491419 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
248 schema:name Animals
249 rdf:type schema:DefinedTerm
250 Ndd725aa96aef41a4affb59c0ba529e7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
251 schema:name Allosteric Regulation
252 rdf:type schema:DefinedTerm
253 Nddf36e1428d441b19d84dbc7e4c35c98 rdf:first sg:person.01317055442.19
254 rdf:rest Na3522de6ae6e450dbf3b079ddefa742d
255 Ne0e544b24d28465cb4c1c44e2fe493e4 rdf:first sg:person.0677166101.67
256 rdf:rest Nc853152d9ccf495f8a12b61540529f7d
257 Ne9738cbde0844d0985faa776121d602b rdf:first sg:person.0646666743.90
258 rdf:rest N40a0ef7656cf47c39c73f97cb92df687
259 Nedc49744c51c4bc7a5502fc0062fc034 schema:volumeNumber 534
260 rdf:type schema:PublicationVolume
261 Nee9e2ec07c3e4b15a25fe6d844cd32ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
262 schema:name Carcinoma, Non-Small-Cell Lung
263 rdf:type schema:DefinedTerm
264 Nf26ca6e651604e8b9dc69e3fbb313d1f rdf:first sg:person.01331013606.47
265 rdf:rest N8bc6ff325681415eb2c09786d0f96754
266 Nf339a56e24a749619fe381ac44d11fc7 rdf:first sg:person.0672052330.04
267 rdf:rest Na5c0abaa1aad4882ad3ac00567ff36d7
268 Nf5f929e19e3a4d53ae35154d5c35fc48 rdf:first sg:person.01243347575.83
269 rdf:rest N5b659addb83648abbc04e4e7d7eb8f5d
270 Nfb2cee6712bf4ac794861760d11e4d3d rdf:first sg:person.0755167624.29
271 rdf:rest N29c9f46848344ffdbcc175904a4de096
272 Nfc4e38687fc1429b88f0531ecae0ba55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
273 schema:name Drug Resistance, Multiple
274 rdf:type schema:DefinedTerm
275 Nfe762edfc741484bbb15c0a88f5503f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
276 schema:name Thiazoles
277 rdf:type schema:DefinedTerm
278 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
279 schema:name Biological Sciences
280 rdf:type schema:DefinedTerm
281 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
282 schema:name Biochemistry and Cell Biology
283 rdf:type schema:DefinedTerm
284 sg:grant.2435835 http://pending.schema.org/fundedItem sg:pub.10.1038/nature17960
285 rdf:type schema:MonetaryGrant
286 sg:grant.2435870 http://pending.schema.org/fundedItem sg:pub.10.1038/nature17960
287 rdf:type schema:MonetaryGrant
288 sg:grant.2478287 http://pending.schema.org/fundedItem sg:pub.10.1038/nature17960
289 rdf:type schema:MonetaryGrant
290 sg:grant.2480038 http://pending.schema.org/fundedItem sg:pub.10.1038/nature17960
291 rdf:type schema:MonetaryGrant
292 sg:grant.2481873 http://pending.schema.org/fundedItem sg:pub.10.1038/nature17960
293 rdf:type schema:MonetaryGrant
294 sg:grant.4729233 http://pending.schema.org/fundedItem sg:pub.10.1038/nature17960
295 rdf:type schema:MonetaryGrant
296 sg:journal.1018957 schema:issn 0028-0836
297 1476-4687
298 schema:name Nature
299 schema:publisher Springer Nature
300 rdf:type schema:Periodical
301 sg:person.01013115571.32 schema:affiliation grid-institutes:grid.418185.1
302 schema:familyName Manuia
303 schema:givenName Mari
304 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013115571.32
305 rdf:type schema:Person
306 sg:person.01017445730.26 schema:affiliation grid-institutes:grid.418185.1
307 schema:familyName Juarez
308 schema:givenName Jose
309 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017445730.26
310 rdf:type schema:Person
311 sg:person.01035160034.34 schema:affiliation grid-institutes:grid.418185.1
312 schema:familyName DiDonato
313 schema:givenName Michael
314 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035160034.34
315 rdf:type schema:Person
316 sg:person.01046707623.60 schema:affiliation grid-institutes:grid.65499.37
317 schema:familyName Xu
318 schema:givenName Chunxiao
319 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046707623.60
320 rdf:type schema:Person
321 sg:person.01061464464.45 schema:affiliation grid-institutes:grid.418185.1
322 schema:familyName McNeill
323 schema:givenName Matthew
324 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061464464.45
325 rdf:type schema:Person
326 sg:person.01077260754.53 schema:affiliation grid-institutes:grid.65499.37
327 schema:familyName Ercan
328 schema:givenName Dalia
329 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077260754.53
330 rdf:type schema:Person
331 sg:person.01163706557.63 schema:affiliation grid-institutes:grid.38142.3c
332 schema:familyName Jang
333 schema:givenName Jaebong
334 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163706557.63
335 rdf:type schema:Person
336 sg:person.01212245744.44 schema:affiliation grid-institutes:grid.38142.3c
337 schema:familyName Eck
338 schema:givenName Michael J.
339 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212245744.44
340 rdf:type schema:Person
341 sg:person.01212567331.89 schema:affiliation grid-institutes:grid.418185.1
342 schema:familyName Epple
343 schema:givenName Robert
344 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212567331.89
345 rdf:type schema:Person
346 sg:person.01243347575.83 schema:affiliation grid-institutes:grid.418185.1
347 schema:familyName Michellys
348 schema:givenName Pierre-Yves
349 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243347575.83
350 rdf:type schema:Person
351 sg:person.01254747015.25 schema:affiliation grid-institutes:grid.418185.1
352 schema:familyName Marsilje
353 schema:givenName Thomas H.
354 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254747015.25
355 rdf:type schema:Person
356 sg:person.01271142403.47 schema:affiliation grid-institutes:grid.418185.1
357 schema:familyName Bursulaya
358 schema:givenName Badry
359 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271142403.47
360 rdf:type schema:Person
361 sg:person.01317055442.19 schema:affiliation grid-institutes:grid.418185.1
362 schema:familyName Lelais
363 schema:givenName Gerald
364 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317055442.19
365 rdf:type schema:Person
366 sg:person.01331013606.47 schema:affiliation grid-institutes:grid.65499.37
367 schema:familyName Zhang
368 schema:givenName Haikuo
369 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331013606.47
370 rdf:type schema:Person
371 sg:person.013337537643.57 schema:affiliation grid-institutes:grid.418185.1
372 schema:familyName Bender
373 schema:givenName Steven
374 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013337537643.57
375 rdf:type schema:Person
376 sg:person.01353217430.16 schema:affiliation grid-institutes:grid.65499.37
377 schema:familyName Palakurthi
378 schema:givenName Sangeetha
379 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353217430.16
380 rdf:type schema:Person
381 sg:person.013640100622.46 schema:affiliation grid-institutes:grid.65499.37
382 schema:familyName Wong
383 schema:givenName Kwok-Kin
384 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013640100622.46
385 rdf:type schema:Person
386 sg:person.016104577635.69 schema:affiliation grid-institutes:grid.65499.37
387 schema:familyName Chen
388 schema:givenName Ting
389 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016104577635.69
390 rdf:type schema:Person
391 sg:person.0600312110.65 schema:affiliation grid-institutes:grid.38142.3c
392 schema:familyName Yun
393 schema:givenName Cai-Hong
394 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600312110.65
395 rdf:type schema:Person
396 sg:person.0646074555.85 schema:affiliation grid-institutes:grid.418185.1
397 schema:familyName Lu
398 schema:givenName Wenshuo
399 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646074555.85
400 rdf:type schema:Person
401 sg:person.0646666743.90 schema:affiliation grid-institutes:grid.418185.1
402 schema:familyName Harris
403 schema:givenName Jennifer
404 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646666743.90
405 rdf:type schema:Person
406 sg:person.0672052330.04 schema:affiliation grid-institutes:grid.65499.37
407 schema:familyName Rhee
408 schema:givenName Kevin
409 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672052330.04
410 rdf:type schema:Person
411 sg:person.0677166101.67 schema:affiliation grid-institutes:grid.418185.1
412 schema:familyName Jia
413 schema:givenName Yong
414 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677166101.67
415 rdf:type schema:Person
416 sg:person.0755167624.29 schema:affiliation grid-institutes:grid.38142.3c
417 schema:familyName Park
418 schema:givenName Eunyoung
419 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755167624.29
420 rdf:type schema:Person
421 sg:person.0767133752.11 schema:affiliation grid-institutes:grid.65499.37
422 schema:familyName Jänne
423 schema:givenName Pasi A.
424 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767133752.11
425 rdf:type schema:Person
426 sg:pub.10.1038/nature08622 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009588480
427 https://doi.org/10.1038/nature08622
428 rdf:type schema:CreativeWork
429 sg:pub.10.1038/nm.3388 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044316748
430 https://doi.org/10.1038/nm.3388
431 rdf:type schema:CreativeWork
432 sg:pub.10.1038/nm.3854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005299046
433 https://doi.org/10.1038/nm.3854
434 rdf:type schema:CreativeWork
435 sg:pub.10.1038/nrclinonc.2013.154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004440239
436 https://doi.org/10.1038/nrclinonc.2013.154
437 rdf:type schema:CreativeWork
438 sg:pub.10.1038/nrclinonc.2014.83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037851851
439 https://doi.org/10.1038/nrclinonc.2014.83
440 rdf:type schema:CreativeWork
441 grid-institutes:grid.38142.3c schema:alternateName Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA
442 schema:name Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA
443 Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215 USA
444 rdf:type schema:Organization
445 grid-institutes:grid.418185.1 schema:alternateName Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA
446 schema:name Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA
447 rdf:type schema:Organization
448 grid-institutes:grid.65499.37 schema:alternateName Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215 USA
449 Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA
450 schema:name Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215 USA
451 Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 USA
452 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...